Renal involvement during graft-versus-host disease following haematopoietic cell transplantation for multiple myeloma has never been described. We report a case of a recipient who developed nephrotic syndrome and membranous glomerulonephritis 22 months after the graft and 6 months after cyclosporine withdrawal. Symptoms resolved when immunosuppressive therapy was reinstituted.

Keywords:
Graft-versus-host disease, Membranous glomerulonephritis, Nephrotic syndrome, Transplantation, Cyclosporine
1.
Gomez-Garcia P, Herrera-Arroyo C, Torres-Gomez A, Gomez-Carrasco J, Alijama-Garcia P, Lopez-Rubio F, Matinez-Guibelalde F, Fornes-Torres G, Rojas-Contreras R: Renal involvement in chronic graft-versus-host disease: A report of two cases. Bone Marrow Transplant 1988;3:357–362.
2.
Hiesse C, Goldschmidt E, Santelli G, Charpentier B, Machover D, Fries D: Membranous nephropathy in a bone marrow transplant recipient. Am J Kidney Dis 1988;11:188–191.
3.
Muller GA, Muller CA, Markovic-Lipkowski J, Bross-Bach U, Schmidt H, Ehninger G, Bohle A, Risler T: Membranous nephropathy after bone marrow transplantation in cyclosporin treatment. Nephron 1989;51:555–556.
4.
Barbara JA, Thomas AC, Smith PS, Gillis D, Ho JOK, Woodroffe AJ: Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient. Clin Nephrol 1992;37:115–118.
5.
Walker JV, Morich D, Anasetti C: Minimal change nephrotic syndrome after cyclosporine withdrawal in a marrow transplant recipient. Am J Kidney Dis 1995;26:532–534.
6.
Sato N, Kishi K, Yagisawa K, Kasama J, Karasawa R, Shimada H, Nishi S, Ueno M, Ito K, Koike T, Takahashi H, Moriyama Y, Arakawa M, Shibata A: Nephrotic syndrome in a bone marrow transplant recipient with chronic graft-versus-host disease. Bone Marrow Transplant 1995;16:303–305.
7.
Yorioka N, Taniguchi Y, Shimote K, Komo T, Yamakido M, Hyodo H, Kimura A, Taguchi T: Membranous nephropathy with chronic graft-versus-host disease in a bone marrow transplant recipient. Nephron 1998;80:371–372.
8.
Oliveira IS, Bahia D, Franco M, Balda C, Stella S, Kerbauy J: Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal. Bone Marrow Transplant 1999;23:99–101.
9.
Nergizoglu G, Keven K, Ates K, Ustun C, Tulunay O, Beksac M, Karatan O, Ertug E: Chronic graft-versus-host disease complicated by membranous glomerulonephritis. Nephrol Dial Transplant 1999;14:2461–2463.
10.
Quaranta S, Shulman H, Ahmed A, Shoenfeld Y, Peter J, McDonald GB, de Water J, Coppel R, Ostlund C, Worman HJ, Rizzetto M, Tsuneyama K, Nakanuma Y, Ansari A, Locatelli F, Paganin S, Rosina F, Manns M, Gershwin ME: Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. Clin Immunol 1999;91:106–116.
11.
Guasch A, Suranyi M, Newton L, Hall BM, Myers BD: Short-term responsiveness of membranous glomerulopathy to cyclosporine. Am J Kidney Dis 1992;20:472–481.
12.
Topaloglu R, Saatci U, Arikan M, Canpinar H, Bakkaloglu A, Kansu E: T-cell subsets, interleukin-2 receptor expression and production of interleukin-2 in minimal change nephritic syndrome. Pediatr Nephrol 1994;8:649–652.
13.
Ferrara JLM, Deeg HJ: Graft-versus-host disease. N Engl J Med 1991;324:667–674.
14.
Allegri L: Antigens in experimental models of membranous nephropathy: Are they involved in human disease? Nephrol Dial Transplant 1997;12:1801–1804.
15.
Imai H, Hamai K, Komatsuda A, Ohtani H, Miura AB: IgG subclasses in patients with membranoproliferative glomerulonephritis membranous nephropathy, and lupus nephritis. Kidney Int 1997;51:270–276.
16.
Oliveira DBG: Membranous nephropathy: An IgG4-mediated disease. Lancet 1998;351:670–671.
17.
Holdsworth SR, Kitching AR, Tipping PG: Th1 and Th2 T helper cell subsets affect pattern of injury and outcomes in glomerulonephritis. Kidney Int 1999;55:1198–1216.
18.
Roccatello D, Coppo R, Amoroso A, Curtoni ES, Martina G, Basolo B, Amore A, Rollino C, Picciotto G, Cordonnier D, et al: Failure to related mononuclear phagocyte system function to HLA-A, B, C, DR, DQ antigens in membranous nephropathy. Am J Kidney Dis 1987;6:470–475.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.